Vertex Pharmaceuticals BDR program executes 8-for-1 stock split in Brazil on July 27

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated

VRTX

0.00
  • Vertex Pharmaceuticals’ BDR program in Brazil will execute a mandatory stock split, issuing 7 additional BDRs for each 1 BDR held.
  • The BDR-to-underlying ratio will shift to 1:32 from 1:4, effective at the market open on 27/07/2026.
  • Key dates: eligible 24/07/2026; ex-date 27/07/2026; record 28/07/2026; new BDR credit 29/07/2026.
  • Fractional entitlements will be settled in cash, net of income tax, with no rounding.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vertex Pharmaceuticals Incorporated published the original content used to generate this news brief on July 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.